Flu season: Manufacturers say they’ve ‘sufficient’ Tamiflu, Relenza

It seems the 2017-2018 influenza season is a rough one according to early reports. The Cdc and Prevention (CDC) reported within their newest Weekly Influenza Report that influenza activity elevated dramatically within the U . s . States. Actually, prevalent influenza activity was as reported by 46 states.

sickImage/mojpe via pixabay

With this particular season’s flu vaccine showing reduced effectiveness, the interest in flu antivirals might be elevated.

The CDC printed the next yesterday in regards to the antiviral drug supply:

Manufacturers have mentioned they’ve sufficient product on hands to satisfy forecasted interest in the 2017-2018 flu season.
As influenza antiviral medicine is mainly used seasonally, patients should consider calling a pharmacy ahead of time to find out if they’ve drug on their own shelf. When the pharmacy doesn’t have product, they might be able to identify another pharmacy in the region which has antiviral drugs available.

CDC will update this site when needed regarding influenza antiviral supply this year.

The next manufacturers have given their contact details for queries associated with product availability:


  • Alvogen Corporation.
    1 (844) 842-8672 Opt. 2
    [email protected]
  • Genentech Customer Support Center
    1 (800) 551-2231


  • GlaxoSmithKline Customer Support Center
    1 (800) 877-1158